Amylyx Pharmaceuticals宣布Avexitide用于减重手术后低血糖症的关键3期LUCIDITY临床试验完成患者入组

美股速递
Mar 24

Amylyx Pharmaceuticals宣布,其针对Avexitide治疗减重手术后低血糖症(PBH)的关键性3期LUCIDITY临床试验已完成患者入组。该研究的完成标志着药物开发进程中的一个重要里程碑。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10